Hydrochlorothiazide may up basal, squamous cell cancer risk

January 6, 2018

(HealthDay)—Hydrochlorothiazide use is associated with an increased risk of non-melanoma skin cancer (NMSC), with evidence of a dose-response relationship, according to a study published online Dec. 3 in the Journal of the American Academy of Dermatology.

Sidsel Arnspang, M.D., from Odense University Hospital in Denmark, and colleagues examined the correlation between hydrochlorothiazide use and the risk of (BCC) and (SCC). Patients with NMSC were identified from the Danish Cancer registry during 2004 to 2012. They were matched in a 1:20 ratio by age and sex with controls.

The researchers found that higher use of hydrochlorothiazide (≥50,000 mg) was associated with odds ratios of 1.29 and 3.98 for BCC and SCC, respectively. There were clear dose-response correlations for hydrochlorothiazide use with BCC and SCC; the odds ratios were 1.54 and 7.38, respectively, for the highest cumulative dose category (≥200,000 mg). There was no for use of other diuretics and antihypertensives with NMSC.

"Hydrochlorothiazide use is associated with a substantially increased risk of NMSC, especially SCC," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Explore further: Popular blood pressure medicine linked with increased risk of skin cancer

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Popular blood pressure medicine linked with increased risk of skin cancer

December 5, 2017
Recently published research from The University of Southern Denmark and the Danish Cancer Society shows a connection between one of the most common medications for hypertension and skin cancer. Danish researchers set their ...

Some RA treatments up second nonmelanoma skin cancer risk

October 29, 2015
(HealthDay)—For patients with rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) with prior nonmelanoma skin cancer (NMSC), the risk of second NMSC varies with different treatments, according to a study published ...

Review: positive link for alcohol, nonmelanoma skin cancer

July 31, 2017
(HealthDay)—Alcohol intake seems to be positively associated with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), according to a review and meta-analysis published online July 28 in the British ...

Arsenic levels higher in patients with nonmelanoma skin cancers

August 22, 2017
(HealthDay)—Certain arsenic species levels are higher among patients with nonmelanoma skin cancer (NMSC), according to a study published online Aug. 16 in the Journal of Dermatology.

Some sun protection behaviors up with history of NMSC

May 23, 2016
(HealthDay)—Individuals with previous nonmelanoma skin cancer (NMSC) are more likely to engage in certain sun protection behaviors than those without previous NMSC, according to a study published online May 16 in the Journal ...

Quenched activity-based probe imaging beneficial in NMSC

January 30, 2017
(HealthDay)—Quenched activity-based probe imaging can discriminate cancer from normal appearing skin tissue, according to a study published in the February issue of the Journal of the American Academy of Dermatology.

Recommended for you

Student develops microfluidics device to help scientists identify early genetic markers of cancer

October 16, 2018
As anyone who has played "Where's Waldo" knows, searching for a single item in a landscape filled with a mélange of characters and objects can be a challenge. Chrissy O'Keefe, a Ph.D. student in the Department of Biomedical ...

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

Technique to 'listen' to a patient's brain during tumour surgery

October 16, 2018
Surgeons could soon eavesdrop on a patient's brain activity during surgery to remove their brain tumour, helping improve the accuracy of the operation and reduce the risk of impairing brain function.

Researchers elucidate roles of TP63 and SOX2 in squamous cell cancer progression

October 16, 2018
Squamous cell carcinomas (SCCs) are aggressive malignancies arising from the squamous epithelium of various organs, such as the esophagus, head and neck, lungs, and skin. Previous studies have demonstrated that two master ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.